We are pleased to share Wellnex Life (ASX: WNX), owner and developer of some of Australia's leading health brands, has recently released a key ASX announcement.
Wellnex Life Limited (ASX: WNX) (“Wellnex” or “the Company”) is pleased to share the letter to shareholders.
After years of hard work and challenges, Wellnex Life now finds itself in a stronger-than-ever position — a momentum shift underpinned by consistent financial performance, strategic execution and a dual-listed footprint across the ASX and London Stock Exchange.
Key Momentum Includes:
1. Grown revenue (CY25 Jan-Apr) to $8.0m, up 46% from the prior corresponding period (“PCP”), with April being particularly strong at 75% growth over April 2024.
2. Grown gross profit (CY25 Jan-Apr) to $3.0m, up 55% from PCP, again with the highest growth (74%) seen in April versus the same month in 2024.
3. Eliminated $13 million in liabilities, removing not only a significant financial burden and refinancing risk, but also saving $1.4m in annual interest cost.
Wellnex Life has reached a pivotal inflection point. The heavy lifting has been done and the foundation for future growth has been built. It is now positioned to reap the benefits of years of work, with the opportunity ahead to scale and succeed.
Congratulations to George Karafotias, Zack Bozinovski, the board and the wider team on this important phase of growth.
Read the full Wellnex Life ASX announcement here.
To learn more about Wellnex Life and stay up to date with investor information, subscribe to the Company's Chairman’s List.
